In a groundbreaking move, the Trump administration has acquired a 9.9% stake in Intel, converting $8.9 billion of CHIPS Act funding into equity. This unprecedented government intervention in the semiconductor industry aims to strengthen domestic manufacturing and align taxpayer interests with corporate success. The deal, which includes non-voting shares and a warrant for additional stock, has garnered bipartisan support and boosted Intel's stock. It comes amid concerns over CEO Lip-Bu Tan's past ties to China and represents a shift in Trump's stance on the CHIPS Act. The agreement signals a more interventionist approach to critical industries, potentially reshaping U.S. industrial policy and the global semiconductor landscape.
In a landmark move that represents an unprecedented level of government intervention in the American semiconductor industry, the Trump administration has finalized a deal to acquire a 9.9% equity stake in Intel. The agreement, announced on August 22, 2025, marks a significant shift in how the U.S. government approaches critical technology sectors and has sparked debate across political lines about the role of government in private enterprise.
The deal’s structure reveals a creative approach to semiconductor funding. While the administration initially presented this as an $8.9 billion investment in Intel common stock, closer examination shows that these funds are not new appropriations but rather previously awarded grants under the Biden administration’s CHIPS and Science Act that had not yet been disbursed. Specifically, the funding includes $5.7 billion from the CHIPS Act and an additional $3.2 billion from the Secure Enclave program, both initiatives of the previous administration.
This arrangement represents a dramatic evolution in President Trump’s stance toward the CHIPS Act. During his campaign, Trump was highly critical of the legislation, calling it a “horrible, horrible thing” and urging House Speaker Mike Johnson to eliminate it. However, rather than scrapping the program entirely, the administration has pivoted to a different approach β converting grants into equity, thereby giving American taxpayers a potential return on their investment rather than providing what Commerce Secretary Howard Lutnick characterized as “free money” to corporations.
The financial details of the transaction reveal the precise mechanics: the U.S. government will receive 433,323,000 shares of common stock, representing 9.9% of Intel’s fully diluted common shares, in exchange for releasing the remaining CHIPS Act funding. According to the agreement, these shares are non-voting, and the government will not receive a board seat, maintaining what Intel described as a “passive” investment without governance rights. Additionally, the government will receive a five-year warrant at $20 per share for an additional 5% of common stock, exercisable only if Intel ceases to own at least 51% of its chip-manufacturing business.
Market reaction to the announcement was immediately positive, with Intel shares surging over 5% during the trading session when the deal was anticipated, though Reuters reported that shares fell approximately 1% in post-market trading after the detailed terms were released. This generally favorable reception reflects investor optimism that the agreement provides Intel with much-needed capital while potentially aligning government interests with the company’s success.
What makes this deal particularly noteworthy is the unusual bipartisan support it has garnered. Senator Bernie Sanders, who typically opposes corporate subsidies, expressed his approval of the arrangement, stating, “If microchip companies make a profit from the generous grants they receive from the federal government, the taxpayers of America have a right to a reasonable return on that investment.” This represents a rare point of agreement between the progressive senator and the Trump administration on economic policy.
The timing of this deal is particularly significant given recent tensions between Trump and Intel CEO Lip-Bu Tan. Earlier in August, Trump had called for Tan’s resignation, accusing him of being “highly conflicted” due to concerns over his previous ties to China. According to reporting by multiple news outlets, concerns escalated when it was revealed that at least eight of Tan’s investments involved entities with military connections. Senator Tom Cotton (R-Arkansas) had also raised concerns, specifically questioning whether Tan had divested from semiconductor firms linked to the Chinese Communist Party or the People’s Liberation Army prior to taking the Intel CEO role.
However, following a personal meeting between Trump and Tan, the president’s tone shifted dramatically. In a post on his social network Truth Social, Trump praised Tan as “highly respected” and credited their negotiation as leading to “a great Deal for America and, also, a great Deal for INTEL.”
For Intel, this investment comes at a critical juncture. Once the undisputed leader in semiconductor manufacturing, the company has struggled in recent years to maintain its technological edge against competitors like Taiwan Semiconductor Manufacturing Company (TSMC) and Samsung. The funding secured through this agreement will support Intel’s ambitious expansion plans, including its new factory in Arizona set to begin high-volume production this year. Intel’s Fab 52 and Fab 62 in Chandler, Arizona represent a significant portion of the company’s $100 billion investment in domestic semiconductor manufacturing capacity. However, questions remain about the company’s delayed facility in Ohio, which according to recent reports has been further postponed, with production now expected to begin no earlier than 2030.
From a national security perspective, the administration views semiconductor production as a vital strategic interest. A White House official characterized the situation as “extraordinary and unique,” noting that Intel is one of a small number of American companies capable of manufacturing advanced chips at scale on domestic soil. The COVID-19 pandemic exposed vulnerabilities in global supply chains, with chip shortages disrupting numerous industries from automotive to consumer electronics. Strengthening domestic semiconductor manufacturing capacity has consequently become a bipartisan priority, even as the approaches differ.
The deal also signals a potentially broader shift in U.S. industrial policy. Commerce Secretary Lutnick has indicated that the administration may pursue similar arrangements with other semiconductor manufacturers who received CHIPS Act funding, including TSMC and Samsung. This suggests a more interventionist approach to critical industries that the administration deems essential to national security and economic competitiveness.
This strategy aligns with other recent moves by the Trump administration in the technology sector, including a revenue-sharing agreement with Nvidia and AMD that gives the government 15% of sales generated through AI chip sales to China in exchange for export licenses. These policies collectively indicate a more assertive approach to capturing value from U.S. technological advantages while attempting to maintain competitiveness in global markets.
Critics of the approach raise legitimate concerns about potential market distortions and the precedent this sets for government intervention in private enterprise. The administration’s equity stake in Intel represents a significant departure from traditional American free-market principles, which have generally limited such direct government ownership to extraordinary circumstances like wartime or financial crises. Questions remain about how this arrangement might affect Intel’s decision-making, relationships with other stakeholders, and competitive dynamics within the semiconductor industry.
Additionally, legal experts have noted potential challenges to the deal’s structure. According to The New York Times, some bankers and lawyers believe the CHIPS Act may not explicitly allow the government to convert its grants to equity, potentially opening the arrangement to legal challenges. The administration has not publicly addressed these concerns but appears confident in the legal foundation of the agreement.
Looking forward, the long-term implications of this deal for both Intel and the broader semiconductor industry remain to be seen. For Intel, the immediate infusion of capital provides breathing room to execute its manufacturing expansion and technological development plans. However, the company still faces formidable challenges in regaining technological leadership and market share from competitors who have surged ahead in recent years.
For the semiconductor industry as a whole, this deal may signal a new era of government involvement, potentially reshaping investment patterns, corporate strategies, and international competition. Other countries, particularly China, have long employed direct government investment and subsidies to build their semiconductor capabilities. The U.S. approach, while still less interventionist than some competitors, is clearly evolving toward more active participation in this strategically critical industry.
As the global technology landscape continues to evolve, the Trump-Intel deal may be remembered as a pivotal moment in U.S. industrial policy β one that challenged traditional boundaries between government and private enterprise in pursuit of technological leadership and national security. Whether this approach will ultimately strengthen or complicate America’s position in the global semiconductor industry remains an open question that will unfold in the years ahead.
